45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
13,485
Insurances with rates
7
CPT / HCPCS codes
6,307
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 191001 | ONASEMNOGENE ABEPARVOVEC-XIOI 2 X 10EXP13 VG/ML IV SUSPENSION,KIT | $3,483,067 | $2,055,009 | — | — | 154 |
| 185618 | TISAGENLECLEUCEL (KYMRIAH) INFUSION- B ALL | $2,719,138 | $1,604,291 | — | — | 6 |
| 187603 | TISAGENLECLEUCEL (KYMRIAH) INFUSION - FL AND LBCL | $2,719,138 | $1,604,291 | — | — | 6 |
| 200756 | CILTACABTAGENE AUTOLEUCEL 0.5 X 10EXP6 TO 1X 10EXP8 CELL IV SUSPENSION | $2,610,278 | $1,540,064 | — | — | 12 |
| 209472 | LIFILEUCEL 7.5 X 10EXP9 TO 72 X 10EXP9 CELL INTRAVENOUS SUSPENSION | $2,575,000 | $1,519,250 | — | — | 6 |
| 198427 | IDECABTAGENE VICLEUCEL (ABECMA) INFUSION - MM | $2,492,040 | $1,470,303 | — | — | 6 |
| 198001 | LISOCABTAGENE MARALEUCEL (BREYANZI) CD8 INJECTION - LBCL | $2,437,387 | $1,438,059 | — | — | 6 |
| 195977 | BREXUCABTAGENE AUTOLEUCEL (TECARTUS) INFUSION - MCL | $2,310,000 | $1,362,900 | — | — | 12 |
| 200118 | BREXUCABTAGENE AUTOLEUCEL (TECARTUS) INFUSION - B-ALL | $2,310,000 | $1,362,900 | — | — | 12 |
| 184992 | AXICABTAGENE CILOLEUCEL (YESCARTA) INFUSION - FL AND LBCL | $2,120,000 | $1,250,800 | — | — | 12 |
| 18 | CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL AND OTHER IMMUNOTHERAPIES | $1,894,346 | $1,117,664 | — | — | 7 |
| 2 | HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITHOUT MCC | $1,413,977 | $834,247 | — | — | 7 |
| 1 | HEART TRANSPLANT OR IMPLANT OF HEART ASSIST SYSTEM WITH MCC | $1,171,293 | $691,063 | — | — | 7 |
| 3 | ECMO OR TRACHEOSTOMY WITH MV GREATER THAN 96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE MOUTH AND NECK | $1,158,132 | $683,298 | — | — | 7 |
| 4 | TRACHEOSTOMY WITH MV GREATER THAN 96 HOURS OR PRINCIPAL DIAGNOSIS EXCEPT FACE MOUTH AND NECK WITHOUT | $1,082,070 | $638,421 | — | — | 7 |
| 5 | LIVER TRANSPLANT WITH MCC OR INTESTINAL TRANSPLANT | $720,578 | $425,141 | — | — | 7 |
| 802 | OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC | $629,003 | $371,112 | — | — | 7 |
| 790 | EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME NEONATE | $521,163 | $307,486 | — | — | 7 |
| 453 | COMBINED ANTERIOR AND POSTERIOR SPINAL FUSION WITH MCC | $499,754 | $294,855 | — | — | 7 |
| 955 | CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA | $480,138 | $283,282 | — | — | 7 |
| 622 | SKIN GRAFTS AND WOUND DEBRIDEMENT FOR ENDOCRINE NUTRITIONAL AND METABOLIC DISORDERS WITH MCC | $457,677 | $270,029 | — | — | 7 |
| 20 | INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH MCC | $453,911 | $267,807 | — | — | 7 |
| 212 | CONCOMITANT AORTIC AND MITRAL VALVE∩â”╜PROCEDURES | $451,862 | $266,599 | — | — | 7 |
| 207 | RESPIRATORY SYSTEM DIAGNOSIS WITH VENTILATOR SUPPORT GREATER THAN 96 HOURS | $427,571 | $252,267 | — | — | 7 |
| 215 | OTHER HEART ASSIST SYSTEM IMPLANT | $368,530 | $217,433 | — | — | 7 |
| 268 | AORTIC AND HEART ASSIST PROCEDURES EXCEPT PULSATION BALLOON WITH MCC | $368,149 | $217,208 | — | — | 7 |
| 939 | O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC | $367,902 | $217,062 | — | — | 7 |
| 901 | WOUND DEBRIDEMENTS FOR INJURIES WITH MCC | $359,202 | $211,929 | — | — | 7 |
| 870 | SEPTICEMIA OR SEVERE SEPSIS WITH MV GREATER THAN 96 HOURS | $358,066 | $211,259 | — | — | 7 |
| 21 | INTRACRANIAL VASCULAR PROCEDURES WITH PRINCIPAL DIAGNOSIS HEMORRHAGE WITH CC | $354,885 | $209,382 | — | — | 7 |
| 117423 | SIPULEUCEL-T IN LACTATED RINGERS 50 MILLION CELL/250 ML IV SUSPENSION | $354,080 | $208,907 | — | — | 7 |
| 456 | SPINAL FUSION EXCEPT CERVICAL WITH SPINAL CURVATURE MALIGNANCY INFECTION OR EXTENSIVE FUSIONS WITH M | $346,224 | $204,272 | — | — | 7 |
| 216 | CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITH CARDIAC CATHETERIZATION WITH MCC | $344,093 | $203,015 | — | — | 7 |
| 834 | ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC | $341,122 | $201,262 | — | — | 7 |
| 957 | OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC | $333,804 | $196,944 | — | — | 7 |
| 275 | CARDIAC DEFIBRILLATOR IMPLANT WITH CARDIAC CATHETERIZATION AND MCC | $329,394 | $194,343 | — | — | 7 |
| 14 | ALLOGENEIC BONE MARROW TRANSPLANT | $310,523 | $183,209 | — | — | 7 |
| 239 | AMPUTATION FOR CIRCULATORY SYSTEM DISORDERS EXCEPT UPPER LIMB AND TOE WITH MCC | $304,374 | $179,580 | — | — | 7 |
| 356 | OTHER DIGESTIVE SYSTEM O.R. PROCEDURES WITH MCC | $300,672 | $177,397 | — | — | 7 |
| 202241 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $298,378 | $176,043 | — | — | 7 |
| 423 | OTHER HEPATOBILIARY OR PANCREAS O.R. PROCEDURES WITH MCC | $298,299 | $175,997 | — | — | 7 |
| 650 | KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC | $285,278 | $168,314 | — | — | 7 |
| 853 | INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | $275,138 | $162,331 | — | — | 7 |
| 804 | OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC-MCC | $273,818 | $161,553 | — | — | 7 |
| 28 | SPINAL PROCEDURES WITH MCC | $272,770 | $160,934 | — | — | 7 |
| 219 | CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MCC | $272,707 | $160,897 | — | — | 7 |
| 23 | CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITH MCC OR CHEMOTHERA | $272,041 | $160,504 | — | — | 7 |
| 232 | CORONARY BYPASS WITH PTCA WITHOUT MCC | $270,484 | $159,585 | — | — | 7 |
| 823 | LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC | $266,735 | $157,374 | — | — | 7 |
| 182699 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $263,607 | $155,528 | — | — | 7 |
Showing top 50 of 13,485 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.